4//SEC Filing
Horn Margaret A 4
Accession 0001610717-24-000509
CIK 0001628171other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 5:31 PM ET
Size
12.1 KB
Accession
0001610717-24-000509
Insider Transaction Report
Form 4
Horn Margaret A
Chief Operating Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-10-11−5,369→ 97,382 totalExercise: $4.09From: 2023-03-13Exp: 2029-03-12→ Common Stock (5,369 underlying) - Exercise/Conversion
Common Stock
2024-10-11$4.09/sh+5,369$21,959→ 182,320 total - Exercise/Conversion
Common Stock
2024-10-11$4.09/sh+44,631$182,541→ 176,951 total - Sale
Common Stock
2024-10-11$50.34/sh−50,000$2,517,055→ 132,320 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-11−44,631→ 0 totalExercise: $4.09From: 2023-03-13Exp: 2029-03-12→ Common Stock (44,631 underlying)
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 22, 2024.
- [F2]Includes 77,300 restricted stock units.
- [F3]This transaction was executed in multiple trades in prices ranging from $50.00 to $50.82, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001294192
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 5:31 PM ET
- Size
- 12.1 KB